Lv5
1440 积分 2023-07-19 加入
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
4天前
已完结
IL-11 is a crucial determinant of cardiovascular fibrosis
4天前
已完结
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
4天前
已完结
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
4天前
已完结
Cancer modeling meets human organoid technology
10天前
已完结
Therapeutic opportunities of the IL-22–IL-22R1 system
16天前
已完结
IL-22 as a target for therapeutic intervention: Current knowledge on its role in various diseases
16天前
已完结
Immune cell-mediated features of non-alcoholic steatohepatitis
16天前
已完结
Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trial
23天前
已完结
Inebilizumab for Treatment of IgG4-Related Disease
23天前
已完结
皖公网安备34019202002308
